Dr. Susanne Muehlschlegel

Neurologist Susanne Muehlschlegel is an internationally known clinician-researcher who specializes in critically ill patients as well as understanding and improving shared decision-making and the ways physicians derive and convey health care recommendations and prognostication to families of neuro-critically ill patients. Her empirical family- and patient-centered research intersects with decision-science, qualitative and mixed-methods research, neurology, neurosurgery, and critical care medicine. She strongly believes that involving families and other stakeholders in her research will positively impact the clinical care of neurocritically ill patients. More about her research: Muehlschlegel Lab Dr. Muehlschlegel earned her medical degree at Philipps-University in Marburg, Germany. She completed an internship in internal medicine followed by residency training at Shands Hospital and Malcolm Randall Veteran Affairs Medical Center at the University of Florida College of Medicine. She finished her fellowship training in neurocritical care at the Harvard Combined Program at Massachusetts General Hospital and Brigham and Women’s Hospital, and she obtained her master’s degree in public health at the Harvard School of Public Health. She is the co-chair of a large international guideline on neuroprognostication, a joint guideline between the Neurocritical Care Society and the German Society for Neuro-Intensive Care Medicine (Deutsche Gesellschaft für Neurointensivmedizin). She served as the leader of the “Curing Coma” Common Data Elements subgroup for “Goals of Care Decisions / Family Data” with national and international group members. She also served as co-chair of the NIH/NINDS-funded Family Experience Workshop after Cardiac Arrest and Severe Neurotrauma.

Dr. Muehlschlegel is highly rated in 6 conditions, according to our data. Her top areas of expertise are Traumatic Brain Injury, Subarachnoid Hemorrhage, Stroke, Craniectomy, and Gastrostomy.

Her clinical research consists of co-authoring 92 peer reviewed articles. MediFind looks at clinical research from the past 15 years.